Company Overview
Spiral Hydrogen is an Estonian CleanTech developer focused on green-hydrogen electrolysis technology. The company operates in the Baltic region, targeting EU-aligned hydrogen projects and Estonia’s energy-security initiatives. With revenue below €10M and zero reported EBITDA, it remains at the pre-commercial stage, emphasizing IP development over scaled manufacturing or recurring revenue.
Deal Context
The €2.7M growth-equity round positions Spiral as a classic deep-tech funding candidate rather than a traditional M&A target. Strategic buyers in energy, utilities, or hydrogen infrastructure are the most plausible future acquirers once technology de-risks; regional PE funds may co-invest for Baltic CleanTech exposure. No founder succession or distress signals are evident.
Valuation Context
Listed Baltic peers trade at 5.6–15.0x EV/EBITDA, with profitable names such as Tallink (7.8x) and Tallinna Sadam (9.1x) setting the upper bound. Applying a 30–50% private-company discount plus an early-stage technology haircut yields an implied 4–7x forward EBITDA once positive margins appear. For revenue-negative hydrogen developers, realistic entry multiples compress to 8–12x ARR or a €8–12M pre-money valuation for the current round, well below listed Baltic cash-flow multiples.
Triage Verdict
REVIEW
- Fit: Sector and geography align tightly with EU hydrogen priorities and the sole announced Baltic CleanTech deal flow.
- Red flags: Zero EBITDA, unproven commercial deployment, and elevated execution risk versus 9–43% margins of listed peers.
- Next step if GO: Request technical due-diligence package and pilot-project pipeline to assess path to first €5M revenue.
Key Risk
Technology never reaches commercial scale, leaving investors with stranded IP and no exit multiple.
Bottom line: Attractive entry to Baltic hydrogen IP, but only after technical milestones are contractually secured.
| # | Fund | AUM | YTD | Positions |
|---|---|---|---|---|
| 1 | Merck & Co., Inc. | $625.7B | +197.2% | 26 |
| 2 | Ma Investment Partnership, LP | $322.6B | +181.4% | 18 |
| 3 | Graticule Asia Macro Advisors LLC | $1.1T | +174.1% | 4 |
| 4 | Shengqi Capital (Hong Kong) Ltd | $95.6B | +167.3% | 10 |
| 5 | Anther Capital Ltd | $3.8T | +153.2% | 31 |
| 6 | Step Capital Management Pte. Ltd. | $467.4B | +152.3% | 53 |
| 7 | Theleme Partners LLP | $3.0T | +130.5% | 20 |
| 8 | Central Asset Investments & Manag… | $261.4B | +130.4% | 63 |
| 9 | Oxbow Capital Management (HK) Ltd | $731.4B | +124.8% | 14 |
| 10 | Elemental Capital Partners LLC | $422.8B | +122.3% | 18 |
| Security | Value | Weight |
|---|---|---|
| MICRON TECHNOLOGY INC | $54.9B | 25.8% |
| MICRON TECHNOLOGY INC | $54.2B | 25.4% |
| ADVANCED MICRO DEVICES INC | $39.2B | 18.4% |
| MODERNA INC | $32.8B | 15.4% |
| ADVANCED MICRO DEVICES INC | $32.1B | 15.1% |
| Company | Ticker | Exchange | Expected | Deal Value |
|---|---|---|---|---|
| SpaceX | SPCX | NASDAQ | 2026-06-12 | — |
| Lycia Therapeutics, Inc. | LYCA | UNKNOWN | TBD | $100.0M |
| DayOne Data Centers Ltd | DODC | UNKNOWN | TBD | $100.0M |
| Pelican Acquisition II Corp | PLCIU | UNKNOWN | TBD | $86.2M |
| GLGHK Ltd | GLG | UNKNOWN | TBD | $40.2M |
| Company | Sector | Valuation |
|---|---|---|
| OpenAI | Artificial Intelligence | $1.2T |
| Anthropic | Artificial Intelligence | $965.0B |
| Databricks | Data and Analytics | $201.6B |
# Match Scorer You score buyer-target compatibility across 7 synergy dimensions. ## Dimensions (each 0-10) 1. **Revenue synergies** (20% weight) — cross-sell, market expansion, pricing, new products. 2. **Cost synergies** (20% weight) — overhead, procurement, systems, facilities. 3. **Strategic fit** (15% weight) — vision, positioning, moat, technology. 4. **Cultural fit** (10% weight) — management style, org, geographic overlap. 5. **Financial health** (15% weight) — balance sheet, cash flow, leverage, earnings quality. 6. **Integration risk** (10% weight, inverted — 10 = LOW risk) — compl…